Brian Ball, MD

Dr. Ball received his medical degree at Georgetown University in Washington, DC, then continued his training at Yale-New Haven Hospital and Memorial Sloan Kettering Cancer Center in New York City. At Yale, he co-directed the school’s Refugee Health Clinic. He’s earned numerous honors and awards, including being selected as chief fellow at Memorial Sloan Kettering and Yale’s coveted Global Health Scholar program enabling him to study in South Africa.

Dr. Ball has a keen interest in researching the molecular mechanisms mediating resistance to current leukemia treatments. One of his proposals for overcoming resistance to apoptosis apoptosis: Programmed cell death. therapies earned him the American Society of Clinical Oncology Young Investigator Award at Memorial Sloan Kettering. He expects to advance and grow his research at City of Hope, a place he lauds as “a leading institution in the field of leukemia and bone marrow transplant bone marrow transplant: A bone marrow transplant (BMT) is also called a stem cell transplant (SCT) or hematopoietic stem cell transplant (HSCT).The procedure replaces unhealthy blood-forming stem cells with healthy ones and offers some patients the possibility of a cure. But for many patients, a BMT is not an option due… .”